BlackRock »

Cytek Biosciences shares owned by BlackRock

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $102M 19M 5.54

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Cytek Biosciences

BlackRock
BlackRock
Vanguard Group
Brown Capital Management
Hillhouse Capital Advisors
State Street Corporation
Geode Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Bank of New York Mellon
Connor, Clark & Lunn Investment Management

View all funds holding Cytek Biosciences